Divergent Motifs but Overlapping Binding Repertoires of Six HLA-DQ Molecules Frequently Expressed in the Worldwide Human Population
暂无分享,去创建一个
Bjoern Peters | J. Sidney | A. Sette | Amiyah Steen | C. Moore | Sandy Ngo | Jolan Chung | Carrie Moore
[1] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[2] R. Zinkernagel,et al. H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus , 1975, The Journal of experimental medicine.
[3] R. Zinkernagel,et al. A BIOLOGICAL ROLE FOR THE MAJOR HISTOCOMPATIBILITY ANTIGENS , 1975, The Lancet.
[4] R. Zinkernagel,et al. H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T- cell specificities are associated with structures coded for in H-2K or H-2D; , 1975, The Journal of experimental medicine.
[5] Robert P. Erickson,et al. Natural history of the major histocompatibility complex , 1987 .
[6] C Oseroff,et al. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. , 1991, Journal of immunology.
[7] J. Sidney,et al. DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles. , 1992, Journal of immunology.
[8] A. Hughes,et al. Maintenance of MHC polymorphism , 1992, Nature.
[9] D. Kwiatkowski,et al. Maintenance of MHC polymorphism , 1992, Nature.
[10] J. Berzofsky,et al. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations. , 1993, Journal of immunology.
[11] M F del Guercio,et al. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. , 1993, Journal of immunology.
[12] Norbert,et al. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. , 1993, The Journal of clinical investigation.
[13] F. Sinigaglia,et al. Promiscuous and allele-specific anchors in HLA-DR-binding peptides , 1993, Cell.
[14] C Oseroff,et al. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. , 1994, Immunity.
[15] Don C. Wiley,et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.
[16] William Arbuthnot Sir Lane,et al. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. , 1994, International immunology.
[17] M F del Guercio,et al. Definition of a DQ3.1-specific binding motif. , 1994, Journal of immunology.
[18] J. Lamb,et al. Overlapping T-cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules. , 1994, The Journal of allergy and clinical immunology.
[19] Partho Ghosh,et al. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.
[20] D. Madden. The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.
[21] K. Wiesmüller,et al. Intramolecular immunodominance and intermolecular selection of H2d-restricted peptides define the same immunodominant region of the measles virus fusion protein. , 1995, Molecular immunology.
[22] F. Sinigaglia,et al. Motifs and supermotifs for MHC class II binding peptides , 1995, The Journal of experimental medicine.
[23] G. Nepom,et al. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. , 1996, Journal of immunology.
[24] M F del Guercio,et al. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. , 1996, Human immunology.
[25] E. Thorsby,et al. Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays. , 1996, Clinical immunology and immunopathology.
[26] H. Rammensee,et al. The peptide binding motif of the disease associated HLA‐DQ (α 1* 0501, β 1* 0201) molecule , 1996 .
[27] R. Zinkernagel,et al. The discovery of MHC restriction. , 1997, Immunology today.
[28] J. Drijfhout,et al. Unique peptide binding characteristics of the disease-associated DQ(α1*0501, β1*0201) vs the non-disease-associated DQ(α1*0201, β1*0202) molecule , 1997, Immunogenetics.
[29] L. Stern,et al. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. , 1997, Structure.
[30] G Chelvanayagam,et al. A roadmap for HLA-DR peptide binding specificities. , 1997, Human immunology.
[31] L. Mitchell,et al. HLA-DR restrictive supertypes dominate promiscuous T cell recognition: association of multiple HLA-DR molecules with susceptibility to autoimmune diseases. , 1997, The Journal of rheumatology.
[32] A Sette,et al. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. , 1997, Journal of molecular biology.
[33] L Raddrizzani,et al. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires. , 1997, Journal of immunology.
[34] W. Kwok,et al. A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus. , 1998, Journal of immunology.
[35] J. Sidney,et al. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. , 1998, Current opinion in immunology.
[36] W A Hendrickson,et al. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. , 1998, Immunity.
[37] D. Jewell,et al. Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection. , 1998, Journal of immunology.
[38] M F del Guercio,et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.
[39] L. Mitchell,et al. A new categorization of HLA DR alleles on a functional basis. , 1998, Human immunology.
[40] S. Buus,et al. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules. , 1998, International immunology.
[41] P. A. Peterson,et al. Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.
[42] G. Nepom,et al. Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype. , 1998, Human immunology.
[43] Johansen,et al. A Peptide‐Binding Assay for the Disease‐Associated HLA‐DQ8 Molecule , 1998, Scandinavian journal of immunology.
[44] J. Sidney,et al. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.
[45] G. Benedek,et al. A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding. , 1999, Biochemistry.
[46] L. Stern,et al. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1. , 1999, Journal of immunology.
[47] John Sidney,et al. HLA-DR-Promiscuous T Cell Epitopes from Plasmodium falciparum Pre-Erythrocytic-Stage Antigens Restricted by Multiple HLA Class II Alleles1 2 , 2000, The Journal of Immunology.
[48] G. Benedek,et al. Determinants of the Peptide-induced Conformational Change in the Human Class II Major Histocompatibility Complex Protein HLA-DR1* , 2000, The Journal of Biological Chemistry.
[49] Andrew W. Liu,et al. β57-Asp Plays an Essential Role in the Unique SDS Stability of HLA-DQA1*0102/DQB1*0602 αβ Protein Dimer, the Class II MHC Allele Associated with Protection from Insulin-Dependent Diabetes Mellitus1 , 2000, The Journal of Immunology.
[50] F Koning,et al. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. , 2000, International immunology.
[51] Don C. Wiley,et al. Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes , 2001, Nature Immunology.
[52] John Sidney,et al. Measurement of MHC/Peptide Interactions by Gel Filtration , 1999, Current protocols in immunology.
[53] S G Marsh,et al. The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. , 2001, Human immunology.
[54] John Sidney,et al. Identification and Antigenicity of Broadly Cross-Reactive and Conserved Human Immunodeficiency Virus Type 1-Derived Helper T-Lymphocyte Epitopes , 2001, Journal of Virology.
[55] P. Roepstorff,et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. , 2002, Gastroenterology.
[56] Craig Beeson,et al. Binding interactions between peptides and proteins of the class II Major Histocompatibility Complex , 2002, Medicinal research reviews.
[57] John Sidney,et al. The HLA Molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 Share an Extensive Overlap in Peptide Binding Specificity1 , 2002, The Journal of Immunology.
[58] Alain Sanson,et al. HLA-DP4, the Most Frequent HLA II Molecule, Defines a New Supertype of Peptide-Binding Specificity1 , 2002, The Journal of Immunology.
[59] J. Strominger,et al. A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[60] E. Albert,et al. Differential peptide binding motif for three juvenile arthritis associated HLA-DQ molecules. , 2003, Clinical and experimental rheumatology.
[61] James Robinson,et al. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex , 2003, Nucleic Acids Res..
[62] Ian A Wilson,et al. Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif. , 2003, Journal of molecular biology.
[63] A. Sanchez‐Mazas,et al. Geographic patterns of functional categories of HLA-DRB1 alleles: a new approach to analyse associations between HLA-DRB1 and disease. , 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[64] N. Balandraud,et al. Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. , 2003, Human immunology.
[65] E. Rosenberg,et al. Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides , 2004, Journal of Virology.
[66] T. Volz,et al. Determination of the peptide binding motif and high-affinity ligands for HLA-DQ4 using synthetic peptide libraries. , 2004, Human immunology.
[67] Arne Svejgaard,et al. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[68] Matthew W. Anderson,et al. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins. , 2004, Chemistry & biology.
[69] O. Lund,et al. Definition of supertypes for HLA molecules using clustering of specificity matrices , 2004, Immunogenetics.
[70] E. Bergseng,et al. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[71] Steve Wilson,et al. The Immune Epitope Database and Analysis Resource: From Vision to Blueprint , 2005, PLoS biology.
[72] Scott A. Brown,et al. T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometry. , 2005, AIDS research and human retroviruses.
[73] Irini A. Doytchinova,et al. In Silico Identification of Supertypes for Class II MHCs1 , 2005, The Journal of Immunology.
[74] Tin Wee Tan,et al. Structural bioinformatics Prediction of HLA-DQ 3 . 2 b Ligands : evidence of multiple registers in class II binding peptides , 2006 .
[75] A. Ménez,et al. Scanning the HIV Genome for CD4+ T Cell Epitopes Restricted to HLA-DP4, the Most Prevalent HLA Class II Molecule1 , 2006, The Journal of Immunology.
[76] V. Brusic,et al. SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens , 2006, Virology.
[77] C. Sanjeevi. Genes Influencing Innate and Acquired Immunity in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults , 2006, Annals of the New York Academy of Sciences.
[78] G. Nepom,et al. Allelic Variation in Key Peptide-Binding Pockets Discriminates between Closely Related Diabetes-Protective and Diabetes-Susceptible HLA-DQB1*06 Alleles1 , 2006, The Journal of Immunology.
[79] Clemencia Pinilla,et al. Characterization of the peptide-binding specificity of the chimpanzee class I alleles A*0301 and A*0401 using a combinatorial peptide library , 2007, Immunogenetics.
[80] Bjoern Peters,et al. HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.
[81] Cisca Wijmenga,et al. Genetic Background of Celiac Disease and Its Clinical Implications , 2008, The American Journal of Gastroenterology.
[82] Morten Nielsen,et al. Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan , 2008, PLoS Comput. Biol..
[83] John Sidney,et al. A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach , 2008, PLoS Comput. Biol..
[84] G. Eisenbarth,et al. Extreme genetic risk for type 1A diabetes in the post-genome era. , 2008, Journal of autoimmunity.
[85] Bjoern Peters,et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries , 2008, Immunome research.
[86] M. Mazzilli,et al. HLA-DQ and risk gradient for celiac disease. , 2009, Human immunology.
[87] L. Sollid,et al. Antigen presentation in celiac disease. , 2009, Current opinion in immunology.
[88] M Setterholm,et al. The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. , 2009, Tissue antigens.
[89] Morten Nielsen,et al. MHC Class II epitope predictive algorithms , 2010, Immunology.
[90] Bjoern Peters,et al. Five HLA-DP Molecules Frequently Expressed in the Worldwide Human Population Share a Common HLA Supertypic Binding Specificity , 2010, The Journal of Immunology.